Portfolio company
eMMUNITY
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops personalised cancer vaccines and diagnostic tools to identify the most effective treatments for oncology patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genevation
This biotechnology company develops personalised mRNA cancer vaccines and therapeutics using artificial intelligence for patients requiring precision oncology treatments.
Swarm Oncology
This biotechnology company develops personalised T cell therapies for patients with advanced solid cancers to achieve long-term remission.
Noetik
This biotechnology company develops precision cancer immunotherapies using machine learning and multimodal human tumour data for pharmaceutical partners and clinical applications.
DualTPharma
This company develops bacteria-based drug delivery systems to transport immunotherapies into solid tumours for cancer patients.
Ventuno Biotech
This biotechnology company develops cancer immunotherapies to stimulate the immune system and treat patients with difficult tumours.
Everimmune
The company develops live biotherapeutic products and diagnostic tools for cancer patients to restore their response to immunotherapy treatments.
BRENUS PHARMA
This company develops allogeneic cancer immunotherapies for patients with solid tumors using a proteomics-guided platform that mimics tumor cell resistance and escape mechanisms.
Bactheravax
This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.
